Zhiyong Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zhiyong Guo has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
Chunjie Li
State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China
5 shared publications- Chunjie Li
State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Head and Neck Oncology West China Hospital of Stomatology, Sichuan University, Chengdu, China
3 shared publications Haosen Lian
3 shared publicationsJiajin Yang
3 shared publicationsCheng Miao
State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, 610041, People’s Republic of China
2 shared publications- Guiquan Zhu
State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, China
2 shared publications
Latest Publications
- 27 August 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 18 (33) , 17523-17558
Clinical translation of carbon nanomaterials: the clinical translation paradox, regulatory barriers, and future pathways
Carbon nanomaterials face a clinical translation paradox where functional complexity conflicts with regulatory predictability. This review offers a practical roadmap for safer, more controllable, and clinically translatable carbon nanotechnologies.
- 27 August 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 18 (33) , 17523-17558
Clinical translation of carbon nanomaterials: the clinical translation paradox, regulatory barriers, and future pathways
Carbon nanomaterials face a clinical translation paradox where functional complexity conflicts with regulatory predictability. This review offers a practical roadmap for safer, more controllable, and clinically translatable carbon nanotechnologies.
- Open Access
- 7 July 2026
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1)
Intelligent surgical workflow recognition-based skill assessment for minimally invasive submandibular gland resection
Artificial Intelligence (AI) is transforming clinical dental practice, with most applications focusing on static images like radiographs. However, the integration of AI in analyzing video data, particularly in surgical settings rich in dynamic information, remains underexplored in oral medicine. This study introduces AI-miSMG, an intelligent surgical workflow recognition model designed for minimally invasive submandibular gland (SMG) resection. Building upon our previous work, we established a standardized annotation protocol to efficiently label endoscopic SMG resection procedures, which are divided into Creation, Position, Separation, Inspection, and Idle phases. The AI-miSMG model was trained on a dataset of 73 high-quality endoscopic SMG resection videos, comprising 386,122 labeled frames. To evaluate its performance, we used a multicenter dataset consisting of surgical videos from four different centers, totaling 85,913 images. The model achieved an overall accuracy of 0.87 on the external validation dataset. Additionally, it was explored for workflow-based analysis of surgical fluency across surgeons with different experience levels. Furthermore, our model reduced annotation time by approximately 47%, decreasing from 94.00 min to 49.90 min. Overall, we developed a deep learning-based workflow recognition model for minimally invasive SMG resection and demonstrated its feasibility for surgical phase recognition, workflow analysis, and model-assisted annotation.
- 7 July 2026
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1)
Open AccessIntelligent surgical workflow recognition-based skill assessment for minimally invasive submandibular gland resection
Artificial Intelligence (AI) is transforming clinical dental practice, with most applications focusing on static images like radiographs. However, the integration of AI in analyzing video data, particularly in surgical settings rich in dynamic information, remains underexplored in oral medicine. This study introduces AI-miSMG, an intelligent surgical workflow recognition model designed for minimally invasive submandibular gland (SMG) resection. Building upon our previous work, we established a standardized annotation protocol to efficiently label endoscopic SMG resection procedures, which are divided into Creation, Position, Separation, Inspection, and Idle phases. The AI-miSMG model was trained on a dataset of 73 high-quality endoscopic SMG resection videos, comprising 386,122 labeled frames. To evaluate its performance, we used a multicenter dataset consisting of surgical videos from four different centers, totaling 85,913 images. The model achieved an overall accuracy of 0.87 on the external validation dataset. Additionally, it was explored for workflow-based analysis of surgical fluency across surgeons with different experience levels. Furthermore, our model reduced annotation time by approximately 47%, decreasing from 94.00 min to 49.90 min. Overall, we developed a deep learning-based workflow recognition model for minimally invasive SMG resection and demonstrated its feasibility for surgical phase recognition, workflow analysis, and model-assisted annotation.
- Open Access
- 1 May 2026
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 21, 1-22
Vesicle-Mediated Delivery of Carbon Dots: Synthesis, Properties, and Biomedical Applications
Carbon dots (CDs), as an emerging class of carbon nanomaterials, exhibit exceptional optical properties, biocompatibility, and functional tunability, rendering them highly promising for applications in biosensing, bioimaging, antibacterial therapy, and phototherapy. However, their small size leads to a poor enhanced-permeation-and-retention (EPR) effect and inadequate targeting capability, which hinders their further translation into biomedical applications. Vesicles, including natural extracellular vesicles (EVs), liposomes, and synthetic vesicles, serve as ideal nanocarriers due to their unique bilayer structure, excellent biocompatibility, and intrinsic targeting properties. The integration of CDs with vesicles forms a novel multifunctional hybrid system, which can effectively address the delivery limitations of CDs while endowing vesicles with additional functionalities such as fluorescence tracing and phototherapeutic effects. This review systematically summarizes the synthesis methods (top-down and bottom-up) and key physicochemical (structural and optical) properties of CDs, as well as the classification and characteristics of various vesicles. Furthermore, it focuses on the construction strategies, interaction mechanisms, and loading methods of CD-vesicle hybrids, and comprehensively elaborates on their applications in targeted drug delivery, bioimaging, tumor therapy, antibacterial treatment, and wound healing. In addition, we critically discuss the key bottlenecks currently limiting the clinical translation of CD–vesicle hybrid therapeutics, including the thermodynamic limitations of drug/CD loading efficiency, burst release of payloads, in vivo pharmacokinetic behavior, and the effects of CDs on vesicle interfacial stability and leakage kinetics. Finally, the current challenges (e.g. unclear interaction mechanisms, limited scalable production, and narrow application scope) and future development directions (e.g. expanding antimicrobial applications, promoting clinical translation, and exploring CD self-assembled vesicles) of CD-vesicle hybrid systems are discussed, aiming to provide a comprehensive reference for the rational design and biomedical application of CD-vesicle hybrid nanomaterials.
- 1 May 2026
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 21, 1-22
Open AccessVesicle-Mediated Delivery of Carbon Dots: Synthesis, Properties, and Biomedical Applications
Carbon dots (CDs), as an emerging class of carbon nanomaterials, exhibit exceptional optical properties, biocompatibility, and functional tunability, rendering them highly promising for applications in biosensing, bioimaging, antibacterial therapy, and phototherapy. However, their small size leads to a poor enhanced-permeation-and-retention (EPR) effect and inadequate targeting capability, which hinders their further translation into biomedical applications. Vesicles, including natural extracellular vesicles (EVs), liposomes, and synthetic vesicles, serve as ideal nanocarriers due to their unique bilayer structure, excellent biocompatibility, and intrinsic targeting properties. The integration of CDs with vesicles forms a novel multifunctional hybrid system, which can effectively address the delivery limitations of CDs while endowing vesicles with additional functionalities such as fluorescence tracing and phototherapeutic effects. This review systematically summarizes the synthesis methods (top-down and bottom-up) and key physicochemical (structural and optical) properties of CDs, as well as the classification and characteristics of various vesicles. Furthermore, it focuses on the construction strategies, interaction mechanisms, and loading methods of CD-vesicle hybrids, and comprehensively elaborates on their applications in targeted drug delivery, bioimaging, tumor therapy, antibacterial treatment, and wound healing. In addition, we critically discuss the key bottlenecks currently limiting the clinical translation of CD–vesicle hybrid therapeutics, including the thermodynamic limitations of drug/CD loading efficiency, burst release of payloads, in vivo pharmacokinetic behavior, and the effects of CDs on vesicle interfacial stability and leakage kinetics. Finally, the current challenges (e.g. unclear interaction mechanisms, limited scalable production, and narrow application scope) and future development directions (e.g. expanding antimicrobial applications, promoting clinical translation, and exploring CD self-assembled vesicles) of CD-vesicle hybrid systems are discussed, aiming to provide a comprehensive reference for the rational design and biomedical application of CD-vesicle hybrid nanomaterials.
- Open Access
- 1 April 2026
- Published by KEAI Publishing in Green Chemical Engineering
Bioinspired engineering of simplified Type I photosensitizers against hypoxic oral squamous cell carcinoma
- 1 April 2026
- Published by KEAI Publishing in Green Chemical Engineering
Open AccessBioinspired engineering of simplified Type I photosensitizers against hypoxic oral squamous cell carcinoma
- 24 September 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (43) , 13905-13927
Carbon dots meet artificial intelligence: applications in biomedical engineering
AI-driven advances in carbon dots (CDs) enable optimized synthesis, enhanced performance, and precise biomedical applications. This review highlights interdisciplinary progress and future directions at the interface of CDs and AI.
- 24 September 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 13 (43) , 13905-13927
Carbon dots meet artificial intelligence: applications in biomedical engineering
AI-driven advances in carbon dots (CDs) enable optimized synthesis, enhanced performance, and precise biomedical applications. This review highlights interdisciplinary progress and future directions at the interface of CDs and AI.
- Open Access
- 1 December 2024
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 14 (12) , 8167-8182
Cutting-edge insights: near-infrared imaging for surgical margin assessment in head and neck tumor resection: a systematic review and meta-analysis
Original Article Cutting-edge insights: near-infrared imaging for surgical margin assessment in head and neck tumor resection: a systematic review and meta-analysis Ke Li, Jiajin Yang, Haosen Lian, Zixi Tian, Chunjie Li, Ning Gao, Zhiyong Guo
- 1 December 2024
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 14 (12) , 8167-8182
Open AccessCutting-edge insights: near-infrared imaging for surgical margin assessment in head and neck tumor resection: a systematic review and meta-analysis
Original Article Cutting-edge insights: near-infrared imaging for surgical margin assessment in head and neck tumor resection: a systematic review and meta-analysis Ke Li, Jiajin Yang, Haosen Lian, Zixi Tian, Chunjie Li, Ning Gao, Zhiyong Guo
- Open Access
- 6 November 2024
- Published by Wiley in Oral Diseases
- Vol. 31 (4) , 1116-1132
Histone Lysine Lactylation (Kla)‐induced BCAM Promotes OSCC Progression and Cis‐Platinum Resistance
Objective: Histone lysine lactylation (Kla) plays a vital role in cancer progression. However, the prognostic value of histone Kla in oral squamous cell carcinoma (OSCC) remains unclear.Materials and Methods: OSCC RNA expression data were obtained from the TCGA and GEO databases. We explored the prognostic value of histone Kla in OSCC via constructing a Cox model and determined the role of Kla in OSCC drug susceptibility and tumor microenvironment (TME). In addition, the biological roles of candidate biomarkers were identified.Results: A total of 1223 Kla‐specific genes were obtained, with 228 DEKlaGs in OSCC. GO and KEGG enrichment analyses suggested that DEKlaGs contributed to inflammatory and cancer progression. A Cox model in accordance with BCAM, CGNL1, DGKG, and OLR1 could predict OSCC patient prognosis accurately. Subsequently, Kla‐induced prognostic genes were identified to play a crucial role in OSCC drug therapy and TME. Moreover, BCAM was identified as a biomarker that promoted OSCC invasion, angiogenesis, and chemotherapy resistance.Conclusion: Kla was identified to be associated with OSCC prognosis, drug therapy, and TME. Histone Kla‐induced BCAM was identified to play a crucial role during OSCC progression, suggesting that Kla is promising to be a novel therapeutic target for OSCC.
- 6 November 2024
- Published by Wiley in Oral Diseases
- Vol. 31 (4) , 1116-1132
Open AccessHistone Lysine Lactylation (Kla)‐induced BCAM Promotes OSCC Progression and Cis‐Platinum Resistance
Objective: Histone lysine lactylation (Kla) plays a vital role in cancer progression. However, the prognostic value of histone Kla in oral squamous cell carcinoma (OSCC) remains unclear.Materials and Methods: OSCC RNA expression data were obtained from the TCGA and GEO databases. We explored the prognostic value of histone Kla in OSCC via constructing a Cox model and determined the role of Kla in OSCC drug susceptibility and tumor microenvironment (TME). In addition, the biological roles of candidate biomarkers were identified.Results: A total of 1223 Kla‐specific genes were obtained, with 228 DEKlaGs in OSCC. GO and KEGG enrichment analyses suggested that DEKlaGs contributed to inflammatory and cancer progression. A Cox model in accordance with BCAM, CGNL1, DGKG, and OLR1 could predict OSCC patient prognosis accurately. Subsequently, Kla‐induced prognostic genes were identified to play a crucial role in OSCC drug therapy and TME. Moreover, BCAM was identified as a biomarker that promoted OSCC invasion, angiogenesis, and chemotherapy resistance.Conclusion: Kla was identified to be associated with OSCC prognosis, drug therapy, and TME. Histone Kla‐induced BCAM was identified to play a crucial role during OSCC progression, suggesting that Kla is promising to be a novel therapeutic target for OSCC.
- 17 July 2024
- Published by Elsevier in Oral Oncology
- Vol. 157, 106956
Current Challenges and Requirements in Robotic Head and Neck Surgery
- 17 July 2024
- Published by Elsevier in Oral Oncology
- Vol. 157, 106956
Current Challenges and Requirements in Robotic Head and Neck Surgery
- 24 April 2023
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 15 (17) , 20726-20741
Carbon Dots from Lycium barbarum Attenuate Radiation-Induced Bone Injury by Inhibiting Senescence via METTL3/Clip3 in an m6A-Dependent Manner
Radiation-induced bone injury management remains a challenge in clinical practice, and there is no effective medicine. Recently, biomass-derived carbon dots (CDs) have attracted attention in biomedical engineering due to the advantages of abundant heteroatoms, low toxicity, and no need to drug loading. Here, we report that CDs, synthesized from Lycium barbarum via hydrothermal strategy, can effectively alleviate radiation-induced bone injury. CCK-8, apoptosis analysis, β-galactosidase staining, quantitative polymerase chain reaction, and western blots demonstrate that CDs can mediate radiation-induced damage and senescence of bone marrow mesenchymal stem cells (BMSCs). CDs regulate osteogenic- and adipogenic-balance after irradiation, shown by alizarin red and oil red O staining. In vivo experiments reveal that CDs prevent the occurrence of osteoradionecrosis in rats, demonstrated by micro-CT and histology examination. The osseointegration of titanium implants installed in irradiated bone is promoted by CDs. Mechanistically, CDs increase the N6-methyladenosine (m6A) level of irradiated BMSCs via the increased methyltransferase-like 3 (METTL3). High-throughput sequencing facilitates detection of increased m6A levels located in the 3'-untranslated regions (UTR) of the CAP-Gly domain containing linker protein 3 (Clip3) mRNA. The dual-luciferase reporter assay shows that 3'UTR is the direct target of METTL3. Subsequently, the increased m6A modification led to enhanced degradation of mRNA and downregulated CLIP3 expression, eventually resulting in the alleviation of radiation-induced bone injury. Interfering with the METTL3/Clip3 axis can antagonize the effect of CDs, indicating that CDs mediate radiation-induced bone injury via the METTL3/Clip3 axis. Taken together, CDs from L. barbarum alleviate radiation-induced bone injury by inhibiting senescence via regulation of m6A modification of Clip3. The present study paves a new pathway for the management of radiation-induced bone injury.
- 24 April 2023
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 15 (17) , 20726-20741
Carbon Dots from Lycium barbarum Attenuate Radiation-Induced Bone Injury by Inhibiting Senescence via METTL3/Clip3 in an m6A-Dependent Manner
Radiation-induced bone injury management remains a challenge in clinical practice, and there is no effective medicine. Recently, biomass-derived carbon dots (CDs) have attracted attention in biomedical engineering due to the advantages of abundant heteroatoms, low toxicity, and no need to drug loading. Here, we report that CDs, synthesized from Lycium barbarum via hydrothermal strategy, can effectively alleviate radiation-induced bone injury. CCK-8, apoptosis analysis, β-galactosidase staining, quantitative polymerase chain reaction, and western blots demonstrate that CDs can mediate radiation-induced damage and senescence of bone marrow mesenchymal stem cells (BMSCs). CDs regulate osteogenic- and adipogenic-balance after irradiation, shown by alizarin red and oil red O staining. In vivo experiments reveal that CDs prevent the occurrence of osteoradionecrosis in rats, demonstrated by micro-CT and histology examination. The osseointegration of titanium implants installed in irradiated bone is promoted by CDs. Mechanistically, CDs increase the N6-methyladenosine (m6A) level of irradiated BMSCs via the increased methyltransferase-like 3 (METTL3). High-throughput sequencing facilitates detection of increased m6A levels located in the 3'-untranslated regions (UTR) of the CAP-Gly domain containing linker protein 3 (Clip3) mRNA. The dual-luciferase reporter assay shows that 3'UTR is the direct target of METTL3. Subsequently, the increased m6A modification led to enhanced degradation of mRNA and downregulated CLIP3 expression, eventually resulting in the alleviation of radiation-induced bone injury. Interfering with the METTL3/Clip3 axis can antagonize the effect of CDs, indicating that CDs mediate radiation-induced bone injury via the METTL3/Clip3 axis. Taken together, CDs from L. barbarum alleviate radiation-induced bone injury by inhibiting senescence via regulation of m6A modification of Clip3. The present study paves a new pathway for the management of radiation-induced bone injury.